Cytek Biosciences, Inc. (CTKB): Total Liabilities
$119.80M
As of 2025-12-31
$124.98M
As of 2026-06-30
+8.4%
3-year compound annual growth
+23.5%
5-year compound annual growth
| Period ended | Total Liabilities | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $119.80M | +15.5% | 2026-02-26, Balance as of period end |
| 2024-12-31 | $103.76M | +2.3% | 2026-02-26, Balance as of period end |
| 2023-12-31 | $101.39M | +7.9% | 2025-02-28, Balance as of period end |
| 2022-12-31 | $93.93M | +62.2% | 2024-03-13, Balance as of period end |
| 2021-12-31 | $57.92M | +38.9% | 2023-03-01, Balance as of period end |
| 2020-12-31 | $41.69M | n/a | 2022-03-17, Balance as of period end |
Total Liabilities at similar companies
| Company | Year ended | Total Liabilities | Change YoY |
|---|---|---|---|
| Cytek Biosciences, Inc. (CTKB) | 2025-12-31 | $119.80M | +15.5% |
| Pacific Biosciences of California, Inc. (PACB) | 2025-12-31 | $778.73M | +3.3% |
| Quanterix Corp (QTRX) | 2025-12-31 | $123.04M | +60.8% |
| Harvard Bioscience Inc (HBIO) | 2025-12-31 | $66.34M | +4.8% |
| 10x Genomics, Inc. (TXG) | 2025-12-31 | $245.04M | +17.5% |
| 908 Devices Inc. (MASS) | 2025-12-31 | $46.37M | +3.3% |
| Rapid Micro Biosystems, Inc. (RPID) | 2025-12-31 | $41.65M | +82.5% |
| EyePoint, Inc. (EYPT) | 2025-12-31 | $57.88M | -29.4% |
| Bionano Genomics, Inc. (BNGO) | 2025-12-31 | $29.16M | -29.4% |
Compare CTKB, PACB, QTRX, HBIO side by side · Screen every company in Laboratory Analytical Instruments ↗